Navigation Links
Uroplasty Appoints Brett Reynolds As Chief Financial Officer
Date:8/12/2013

MINNEAPOLIS, Aug. 12, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced the appointment of Brett A. Reynolds as Senior Vice President and Chief Financial Officer. He joins Uroplasty following 10 years in senior positions, including Chief Financial Officer, with Synovis Life Technologies, a Twin Cities based medical device manufacturer acquired by Baxter International last year. 

"Brett's significant industry operational experience and proven public company financial leadership will be a valuable asset to Uroplasty.  His track record of building strong financial organizations and processes expands the depth of our executive leadership team and we are delighted to have him on board in this key role," said Rob Kill, President & CEO of Uroplasty.

Mr. Reynolds experience spans more than 20 years in finance and operations.  He was most recently the CFO of Synovis, staying on with the company as Site Leader following its sale to Baxter International in February 2012 for $325 million. Prior to Synovis, Mr. Reynolds served in executive financial positions at Chiquita Processed Foods, Arthur Andersen and Deloitte & Touche.

Mr. Reynolds is a Certified Public Accountant and holds a BA in Accounting and an MBA from the University of Minnesota's Carlson School of Management.

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom is a global medical company committed to offering transformative treatment options to specialty physicians.  Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared system that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.

Forward-Looking Information
This press release contains forward-looking statements that reflect our best estimates regarding future events and financial performance.  These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our anticipated results.  We discuss in detail the factors that may affect the achievement of our forward-looking statements in our Annual Report on Form 10-K filed with the SEC.

For Further Information:
Uroplasty, Inc.
Rob Kill, President and CEO
952.426.6151

EVC Group
Jenifer Kirtland (Investors)/Janine McCargo (Business Media)
415.568.9349/646.688.0245


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
2. Uroplasty Announces Product Development and New Clinical Trial Initiatives
3. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
4. Uroplasty To Present At The JMP Securities Healthcare Conference
5. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
6. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
7. Uroplasty To Participate In Two Upcoming Conferences
8. Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
9. Uroplasty To Participate In Two Upcoming Investor Conferences
10. Uroplasty To Participate In The Oppenheimer 23rd Annual Healthcare Conference
11. Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... 5, 2017 Pace Analytical, a company of over 2,000 employees and ... have acquired ESC Lab Sciences, further solidifying their position as the top American ... . ... and CEO of Pace Analytical ... out of Mt Juliet, TN , enhances Pace Analytical,s capability ...
(Date:6/30/2017)... 30, 2017 In vitro diagnostics market firm ... May, at least ten diagnostic companies have successfully completed ... offerings and a loan facility.  The size of these ... million.  Kalorama Information provides a monthly IVD Market ... Knowledge Center. ...
(Date:6/27/2017)... June 27, 2017  Therapix Biosciences Ltd. (Nasdaq: ... specializing in the development of cannabinoid-based drugs, today announced ... Opening Bell in New York, NY ... its initial public offering (IPO) of American Depository Shares ... 2017. Dr. Elran Haber, Ph.D., Chief Executive ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... July 19, 2017 , ... Adolfson & ... project manager, Josh Christensen. As a leader in healthcare construction, AP has successfully ... healthcare resume in the Midwest with Josh now on board. , Josh ...
(Date:7/18/2017)... ... July 18, 2017 , ... CannaKids, a California Cooperative ... oils, announced today that at the WORLDZ Summit, taking place in Hollywood from ... the therapeutic benefits of medical cannabis for both pediatric and adult patients, and how ...
(Date:7/18/2017)... ... 2017 , ... An inventor from Anacortes, Wash., knows the difficulties and indignity ... hot flashes, and I suffer from anxiety and vertigo on top of that," she ... and about." INSTA-FAN meets that need. , This device enables a woman in menopause ...
(Date:7/17/2017)... VIRGINIA (PRWEB) , ... July 17, 2017 , ... ... Defects Research: Depression and Its Treatments during Pregnancy , studies take a closer ... the disease on a developing baby with one study showing newer medications may ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... announced a partnership with the Texas Academy of Family Physicians (TAFP) ... October 20-22, 2017 at the Hyatt Regency Dallas in Dallas, Texas.     , CRS ...
Breaking Medicine News(10 mins):